Iranian Journal of Pediatrics

Published by: Kowsar

Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura

Meltem Erol 1 , * , Ozgul Yigit 1 , Mehmet Tasdemir 2 , Ozlem Bostan Gayret 1 , Ovgu Buke 1 , Aysegul Gunes 3 , Sahin Hamilcikan 1 and Ozgur Kasapcopur 4
Authors Information
1 Department of Pediatrics, Bagcilar Training and Research Hospital, Istanbul, Turkey
2 Department of Pediatric Nephology, Koc University Hospital, Istanbul, Turkey
3 Department of Biochemistry, Bagcilar Training and Research Hospital, Istanbul, Turkey
4 Department of Pediatric Rheumatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e6129
  • Published Online: June 5, 2016
  • Article Type: Research Article
  • Received: March 25, 2016
  • Revised: April 19, 2016
  • Accepted: May 10, 2016
  • DOI: 10.5812/ijp.6129

To Cite: Erol M, Yigit O, Tasdemir M, Bostan Gayret O, Buke O, et al. Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura, Iran J Pediatr. 2016 ; 26(4):e6129. doi: 10.5812/ijp.6129 .

Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Yi ZW, Fang XL, Wu XC, He XJ, He QN, Dang XQ, et al. Role of PAX2 gene polymorphisms in Henoch-Schonlein purpura nephritis. Nephrology (Carlton). 2006; 11(1): 42-8[DOI][PubMed]
  • 2. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2010; 25(1): 19-26[DOI][PubMed]
  • 3. Davin JC, Weening JJ. Henoch-Schonlein purpura nephritis: an update. Eur J Pediatr. 2001; 160(12): 689-95[PubMed]
  • 4. Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schonlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci. 2013; 59(1): 15-26[PubMed]
  • 5. de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007; 83(3): 259-66[DOI][PubMed]
  • 6. Hung SH, Yang YH, Lee CC, Wang LC, Lin YT, Chiang BL. Clinical predictors of self-limited urinalysis abnormality in childhood Henoch-Schonlein purpura nephritis. Acta Paediatr. 2006; 95(3): 306-11[DOI][PubMed]
  • 7. Qin YH, Zhou TB, Lei FY, Huang WF, Zhao YJ, Lin FQ, et al. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children? Nephrology (Carlton). 2011; 16(1): 93-9[DOI][PubMed]
  • 8. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol. 2000; 11(3): 574-81[PubMed]
  • 9. Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol. 2007; 292(3)-11[DOI][PubMed]
  • 10. Ma H, Lin H, Ma G. Urinary levels of collagen IV and MMP-9 and their clinical significances in children with Henoch–Schonlein purpura. Med Innov Res. 2008; 5: 8-9
  • 11. Wang SM, Qi X, Pan T, Xu L. The Relationship between Urinary Microprotein and Metalloproteinase-9 Expression in Children with Nephritis of Schonle-Henoch Purpura. J Hubei Univ Med. 2010; 29: 515-7
  • 12. Li C, Chen Q, Zhang Y, Wang M, Ke P. Changes and clinical significance of matrix metalloproteinase-9 in children with Henoch–Schonlein purpura nephritis. Guangdong Med J. 2011; 32: 2945–6
  • 13. Zhu QY, Jiang YH, Liu JD, Sun Q. Significance of Changes of Serum Levels and Ratios of Matrix Nephritis Metalloproteinase-2,-9 and Tissue Inhibitor of Metalloproteinase-1 in Children with Henoch-Schonlein Purpura Nephristis. J Appl Clin Pediatr. 2007; 22(5): 343-4
  • 14. Caim W, Li A, Chen S, Li C, Cui H. Clinical significance of the change of matrix metalloproteinase-9 children with Henoch-Schönlein purpura nephritis. Shandong Med J . 2007; 47: 42-3
  • 15. Wang YB AS. Matrix metalloproteinase 2, 9 and its tissue inhibitor 1 expression and their significance in the Henoch–Schönlein purpura nephritis. Harbin Med J. 2009; 29: 13-4
  • 16. Lu Y. The clinical significance of the detection of matrix metalloproteinase 9 in children with Henoch–Schönlein purpura nephritis. Mod Pract Med. 2010; 22: 1178-80
  • 17. Yu Z, Peng X. The changes and clinical significance of IL-6, IL-8, MMP-9 in serum of children with Henoch–Schönlein purpura nephritis. T Hebei Med. 2008; 14: 573-6
  • 18. Geng XH, Zhang H. Relationship between Matrix Metalloproteinase Level and Kidney Damage in Children with Henoch-Schonlein Purpura Nephritis. J Henan Univ Sci Tech (Med Sci). 2011; 29: 100-2
  • 19. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006; 65(7): 936-41[DOI][PubMed]
  • 20. McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG, et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int Suppl. 2000; 77-7[PubMed]
  • 21. Tveita A, Rekvig OP, Zykova SN. Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis. Arthritis Res Ther. 2008; 10(6): 229[DOI][PubMed]
  • 22. Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2004; 19(6): 1412-9[DOI][PubMed]
  • 23. Danilewicz M, Wagrowska-Danilewicz M. Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis. Folia Histochem Cytobiol. 2010; 48(1): 63-7[DOI][PubMed]
  • 24. Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal. 2004; 18(3): 206-10[DOI][PubMed]
  • 25. Shin JI, Song KS, Kim H, Cho NH, Kim J, Kim HS, et al. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schonlein purpura. Br J Dermatol. 2011; 164(6): 1348-55[DOI][PubMed]
  • 26. Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail. 2013; 35(3): 425-9[DOI][PubMed]
  • 27. Zou CC, Zhao ZY, Tang LF, Liang L. Plasma levels of matrix metalloproteinase-9 in Henoch-Schonlein purpura. Scand J Rheumatol. 2006; 35(1): 52-5[DOI][PubMed]
  • 28. Ebihara I, Nakamura T, Shimada N, Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1998; 32(4): 544-50
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments